Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01292005 · ClinicalTrials.gov registry record · Early Phase 1

Pentoxifylline Treatment of Acute Pancreatitis

A Early Phase 1 study of Acute Pancreatitis, sponsored by Mayo Clinic.

Completed
Registry status
Early Phase 1
Development phase
28
Enrollment target
1
Study location

NCT01292005 is a Early Phase 1 study of Acute Pancreatitis that has completed, run by Mayo Clinic. The registered enrollment target is 28 participants, below the 2,316-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01292005, a Early Phase 1 study of Acute Pancreatitis, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
Early Phase 1
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis, to see if it can improve blood tests associated with inflammation (tissue damage). Pentoxifylline is approved by the US Food and Drug Administration (FDA) for treatment of circulation problems, but its use in this study is investigational, which means that the FDA has not approved it for the treatment of pancreatitis. However, the FDA has allowed the use of pentoxifylline in this research study.

Conditions Studied

Acute Pancreatitis

Interventions

  • DRUG Placebo
  • DRUG Pentoxifylline

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2009-04
Est. Completion 2012-07
Phase Early Phase 1

Sponsor

Mayo Clinic

2,844 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01292005

The ClinicalTrials.gov registry entry for NCT01292005 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,316-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (99% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Pancreatitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01292005 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT01292005 about?

NCT01292005 is a clinical study titled "Pentoxifylline Treatment of Acute Pancreatitis". The purpose of this study is to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis, to see if it can improve blood tests associated with inflammation (tissue damage). Pentoxifylline is approved by the US Food and Drug Administration (FDA) ...

What is the current status of trial NCT01292005?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2009-04. Estimated completion is 2012-07.

What conditions does trial NCT01292005 study?

This clinical trial studies the following conditions: Acute Pancreatitis.

What interventions are being tested in trial NCT01292005?

The interventions under investigation include: Placebo (DRUG), Pentoxifylline (DRUG).

Who is sponsoring clinical trial NCT01292005?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01292005 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Pancreatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Pancreatitis

All registered trials for this condition

Minnesota

All trials with a study site in Minnesota

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.